KRSNAA DIAGNOSTICS share price has zoomed 3% and is presently trading at Rs 628.9.
Meanwhile, the BSE HEALTHCARE index is at 37,159.3 (down 0.2%).
Among the top gainers in the BSE HEALTHCARE index today are ALEMBIC PHARMA (up 5.2%) and AARTI DRUGS (up 3.1%).
MAX HEALTHCARE INSTITUTE (down 4.4%) and FORTIS HEALTHCARE (down 2.9%) are among the top losers today.
Over the last one year, KRSNAA DIAGNOSTICS has moved up from Rs 567.3 to Rs 628.9, registering a gain of Rs 61.6 (up 10.8%).
On the other hand, the BSE HEALTHCARE index has moved up from 25,634.3 to 37,159.3, registering a gain of 45.0% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were Glenmark Pharma (up 84.8%), Cadila Healthcare (up 83.9%) and Lupin (up 83.8%).
Dear Reader: If You Invest in Midcap Stocks, this is for You
The BSE Sensex is at 79,441.5 .
The top losers among the BSE Sensex today are Kotak Bank (down 2.4%) and Bharti Airtel (down 2.3%). The most traded stocks in the BSE Sensex are Tata Steel and SBI.
In the meantime, NSE Nifty is at 24,117.8 (down 0.1%). Shriram Transport and Kotak Bank are among the top losers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 63,915.4 to 79,441.5, registering a gain of 15,526.0 points (up 24.3%).
KRSNAA DIAGNOSTICS net profit fell 1.0% YoY to Rs 187 million for the quarter ended March 2024, compared to a profit of Rs 189 million a year ago. Net sales rose 24.8% to Rs 1,663 million during the period as against Rs 1,332 million in January-March 2023.
For the year ended March 2023, KRSNAA DIAGNOSTICS reported 9.2% decrease in net profit to Rs 621 million compared to net profit of Rs 684 million during FY22. Revenue of the company grew 7.0% to Rs 4,871 million during FY23.
The current Price to earnings ratio of KRSNAA DIAGNOSTICS, based on rolling 12 month earnings, stands at 35.7.
Equitymaster requests your view! Post a comment on "KRSNAA DIAGNOSTICS Gains 3%; BSE HEALTHCARE Index Down 0.2%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!